These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18433022)

  • 21. A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.
    Anty R; Iannelli A; Patouraux S; Bonnafous S; Lavallard VJ; Senni-Buratti M; Amor IB; Staccini-Myx A; Saint-Paul MC; Berthier F; Huet PM; Le Marchand-Brustel Y; Gugenheim J; Gual P; Tran A
    Aliment Pharmacol Ther; 2010 Dec; 32(11-12):1315-22. PubMed ID: 21050233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study.
    Jouët P; Sabaté JM; Maillard D; Msika S; Mechler C; Ledoux S; Harnois F; Coffin B
    Obes Surg; 2007 Apr; 17(4):478-85. PubMed ID: 17608260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.
    Guichelaar MM; Gawrieh S; Olivier M; Viker K; Krishnan A; Sanderson S; Malinchoc M; Watt KD; Swain JM; Sarr M; Charlton MR
    Obesity (Silver Spring); 2013 Sep; 21(9):1935-41. PubMed ID: 23418085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
    Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
    Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
    Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
    Liew PL; Lee WJ; Wang W; Lee YC; Chen WY; Fang CL; Huang MT
    Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease.
    Machado MV; Gonçalves S; Carepa F; Coutinho J; Costa A; Cortez-Pinto H
    Liver Int; 2012 Feb; 32(2):241-8. PubMed ID: 22098270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Verma S; Jensen D; Hart J; Mohanty SR
    Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.
    Neuschwander-Tetri BA; Clark JM; Bass NM; Van Natta ML; Unalp-Arida A; Tonascia J; Zein CO; Brunt EM; Kleiner DE; McCullough AJ; Sanyal AJ; Diehl AM; Lavine JE; Chalasani N; Kowdley KV;
    Hepatology; 2010 Sep; 52(3):913-24. PubMed ID: 20648476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.
    Dixon JB; Bhathal PS; O'Brien PE
    Gastroenterology; 2001 Jul; 121(1):91-100. PubMed ID: 11438497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
    López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
    Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome.
    Setji TL; Holland ND; Sanders LL; Pereira KC; Diehl AM; Brown AJ
    J Clin Endocrinol Metab; 2006 May; 91(5):1741-7. PubMed ID: 16492691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
    Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
    Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease.
    Cerović I; Mladenović D; Ješić R; Naumović T; Branković M; Vučević D; Aleksić V; Radosavljević T
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):899-904. PubMed ID: 23426271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
    Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM
    Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.
    Xanthakos S; Miles L; Bucuvalas J; Daniels S; Garcia V; Inge T
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score.
    Tan CH; Al-Kalifah N; Ser KH; Lee YC; Chen JC; Lee WJ
    Surg Obes Relat Dis; 2018 Oct; 14(10):1600-1606. PubMed ID: 30077664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.